Cargando…
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints
Cancer immunotherapy is fast becoming one of the most promising means of treating malignant disease. Cancer vaccines, adoptive cell transfer therapies, and immune checkpoint blockade have all shown varying levels of success in the clinical management of several cancer types in recent years. However,...
Autor principal: | Hargadon, Kristian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240858/ https://www.ncbi.nlm.nih.gov/pubmed/32508018 http://dx.doi.org/10.1002/ctm2.37 |
Ejemplares similares
-
Tumor-Altered Dendritic Cell Function: Implications for Anti-Tumor Immunity
por: Hargadon, Kristian M.
Publicado: (2013) -
The extent to which melanoma alters tissue-resident dendritic cell function correlates with tumorigenicity
por: Hargadon, Kristian Michael
Publicado: (2015) -
The Role of Tumor/Dendritic Cell Interactions in the Regulation of Anti-Tumor Immunity: The Good, the Bad, and the Ugly
por: Hargadon, Kristian Michael, et al.
Publicado: (2014) -
Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma
por: Hargadon, Kristian M.
Publicado: (2017) -
CCR2 of Tumor Microenvironmental Cells Is a Relevant Modulator of Glioma Biology
por: Felsenstein, Matthäus, et al.
Publicado: (2020)